1,578
Views
17
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Clinically significant responses achieved with romidepsin across disease compartments in patients with cutaneous T-cell lymphoma

, , , , , , , , , , & show all
Pages 2847-2854 | Received 29 Aug 2014, Accepted 22 Jan 2015, Published online: 20 May 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Mehul Dalal, Stephen Mitchell, Conor McCloskey, Erin Zagadailov & Ashish Gautam. (2020) The clinical and humanistic burden of cutaneous T-cell lymphomas and response to conventional and novel therapies: results of a systematic review. Expert Review of Hematology 13:4, pages 405-419.
Read now
Piotr Smolewski & Tadeusz Robak. (2017) The discovery and development of romidepsin for the treatment of T-cell lymphoma. Expert Opinion on Drug Discovery 12:8, pages 859-873.
Read now

Articles from other publishers (15)

Mitchell N. Lefebvre, Nicholas Borcherding, Ryan J. Reis, Eric Mou, Vincent Liu & Ali Jabbari. (2023) Molecular techniques drive cutting edge advancements in management of cutaneous T cell lymphoma. Frontiers in Immunology 14.
Crossref
Hyewon Lee. (2023) Mycosis fungoides and Sézary syndrome. Blood Research 58:S1, pages S66-S82.
Crossref
Michael S. Khodadoust, Eric Mou & Youn H. Kim. (2023) Integrating novel agents into the treatment of advanced mycosis fungoides and Sézary syndrome. Blood 141:7, pages 695-703.
Crossref
Adam J. Kleinman, Sindhuja Sivanandham, Paola Sette, Ranjit Sivanandham, Benjamin B. Policicchio, Cuiling Xu, Ellen Penn, Egidio Brocca-Cofano, Quentin Le Hingrat, Dongzhu Ma, Ivona Pandrea & Cristian Apetrei. (2022) Changes to the Simian Immunodeficiency Virus (SIV) Reservoir and Enhanced SIV-Specific Responses in a Rhesus Macaque Model of Functional Cure after Serial Rounds of Romidepsin Administrations. Journal of Virology 96:12.
Crossref
Tarsheen K. Sethi, Francesca Montanari, Francine Foss & Nishitha Reddy. (2021) How we treat advanced stage cutaneous T‐cell lymphoma – mycosis fungoides and Sézary syndrome. British Journal of Haematology 195:3, pages 352-364.
Crossref
Caitlin M. Brumfiel, Meera H. Patel, Pranav Puri, Jake Besch-Stokes, Scott Lester, William G. Rule, Nandita Khera, Jason C. Sluzevich, David J. DiCaudo, Nneka Comfere, N. Nora Bennani, Allison C. Rosenthal, Mark R. Pittelkow & Aaron R. Mangold. (2021) How to Sequence Therapies in Mycosis Fungoides. Current Treatment Options in Oncology 22:11.
Crossref
José Antonio Sanches, Jade Cury-Martins, Rodrigo Martins Abreu, Denis Miyashiro & Juliana Pereira. (2021) Mycosis fungoides and Sézary syndrome: focus on the current treatment scenario. Anais Brasileiros de Dermatologia 96:4, pages 458-471.
Crossref
Ping Zhang & Mingzhi Zhang. (2021) Epigenetics in the Pathogenesis and Treatment of Cutaneous T-Cell Lymphoma. Frontiers in Oncology 11.
Crossref
Neha Mehta-ShahSteven M. HorwitzStephen AnsellWeiyun Z. AiJeffrey BarnesStefan K. BartaMark W. ClemensAhmet DoganKristopher FisherAaron M. GoodmanGaurav GoyalJoan GuitartAhmad HalwaniBradley M. HaverkosRichard T. HoppeEric JacobsenDeepa JagadeeshMatthew A. LunningAmitkumar MehtaElise A. OlsenBarbara ProSaurabh A. RajguruSatish ShanbhagAaron ShaverAndrei ShustovLubomir SokolPallawi TorkaCarlos Torres-CabalaRyan WilcoxBasem M. WilliamJasmine Zain, Mary A. DwyerHema SundarYoun H. Kim. (2020) NCCN Guidelines Insights: Primary Cutaneous Lymphomas, Version 2.2020. Journal of the National Comprehensive Cancer Network 18:5, pages 522-536.
Crossref
Khoan Vu, Chi-Heng Wu, Chen-Yen Yang, Aaron Zhan, Erika Cavallone, Wade Berry, Pamela Heeter, Laura Pincus, Matthew J. Wieduwilt, Basem M. William, Charalambos Andreadis, Lawrence K. Kaplan, Frank McCormick, Pierluigi Porcu, Jonathan E. Brammer & Weiyun Z. Ai. (2020) Romidepsin Plus Liposomal Doxorubicin Is Safe and Effective in Patients with Relapsed or Refractory T-Cell Lymphoma: Results of a Phase I Dose-Escalation Study. Clinical Cancer Research 26:5, pages 1000-1008.
Crossref
Adriana T. Lopez, Susan Bates & Larisa Geskin. (2018) Current Status of HDAC Inhibitors in Cutaneous T-cell Lymphoma. American Journal of Clinical Dermatology 19:6, pages 805-819.
Crossref
Halle Field, Ling Gao, Pooja Motwani & Henry K. Wong. (2016) Pruritus Reduction with Systemic Anti-lymphoma Treatments in Patients with Cutaneous T Cell Lymphoma: A Narrative Review. Dermatology and Therapy 6:4, pages 579-595.
Crossref
Francine Foss, Madeleine Duvic, Adam Lerner, Joel Waksman & Sean Whittaker. (2016) Clinical Efficacy of Romidepsin in Tumor Stage and Folliculotropic Mycosis Fungoides. Clinical Lymphoma Myeloma and Leukemia 16:11, pages 637-643.
Crossref
Sunil A. Reddy. (2016) Romidepsin for the treatment of relapsed/refractory cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome): Use in a community setting. Critical Reviews in Oncology/Hematology 106, pages 99-107.
Crossref
Sean WhittakerRichard Hoppe & H. Miles Prince. (2016) How I treat mycosis fungoides and Sézary syndrome. Blood 127:25, pages 3142-3153.
Crossref